Schedule 13G ownership disclosure
ANIKA THERAPEUTICS INC
Security class unavailable · CUSIP: 035255108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,764,607
- Percent of class
- 11.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-24-003689
- Form type
- SC 13G
- Filer
- Anika Therapeutics, Inc.
- CIK
- CIK 898437
- Filed
- Nov 08, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership